³Ô¹ÏÍøÕ¾

Latest clinical trial News

Funding Gift For Spinal Injury Clinical Trial
Medidata Secures Highest Leadership Position in Everest Group’s First Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment
MEB Receives 86 Millions In Swedish Grants
³Ô¹ÏÍøÕ¾ Anti-vaping Program For Young Australians
‘Sleepy cannabis’: first objective study to show cannabinol increases sleep
Recce says patient dosing in Phase 2 clinical trial advances to final stages
Suffering from recurrent UTIs? Join clinical trial testing natural preventative
Ryan’s “I Was Told I Would Be Dead By Christmas”
Alzheimer’s treatment donanemab is not a ‘miracle drug’ – not providing it on the NHS is the right choice
Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials, Accelerating Study Design and Execution
First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease
New algorithm picks fairer shortlist when applicants abound
Polycystic ovary syndrome needs better management: study
What is stereotactic radiation therapy for prostate cancer? How does it compare to other treatments?
Seaport Therapeutics secures US$225 Series B funding to develop neuropsychiatric medicines using Monash University prodrug technology
Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent…
Mater Launches Trial Of Combined COVID-flu Vaccine
Combining two common medications may pave the way for a new dementia treatment
Chimeric says cancer patient achieves complete response in CHM CORE-NK trial
Hoarding disorder: ‘sensory CBT’ treatment strategy shows promise
Drug Trial Studies Oral Cancer Therapy For Dogs
GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
Hoarding disorder: ‘sensory CBT’ treatment strategy shows promise
New drug could be answer to an overlooked yet devastating type of dementia
Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan
Nanoscope Therapeutics Licenses Optogenetic Technology
Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta® (pertuzumab) Biosimilar Candidate HLX11
Logan Hospital LEADS Awarded Centre Of Excellence
Chimeric announces new collaboration with Achieve Clinics
PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
Vaxxas initiates Phase 1 clinical trial of pre-pandemic Avian Influenza A Virus vaccine
World-first Florey research aims to rapidly and accurately screen drugs to treat motor neurone disease
Biotron updates on BIT225-012 Phase 2 COVID-19 clinical trial
Nyrada provides update on its brain injury program GLP studies
Percheron Therapeutics announces positive preclinical data for avicursen
Blood stem cell breakthrough could transform bone marrow transplants
Depressed Adolescents Twice As Likely To Vape
Novel low-dose 3-in-1 blood pressure pill significantly outperforms standard care, study shows
Transformation On Agenda At Southern’s Research Office
NeuRA launches world’s largest clinical trial for phantom limb pain
Widespread Risk Screening Could Slash Dementia Cases
Creative arts therapy programs can help health care workers dance, write and draw their way through burnout and on-the-job stress
From thoughts to words: How AI deciphers neural signals to help a man with ALS speak
Amplia says five patients recording sustained reduction in tumour size in trial
Counselling May Prevent Heart Attacks
PCI Pharma Services’ Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
Chimeric says Phase 1/2 CHM CDH17 CAR-T GMP manufacturing complete